- Packaging TypeBox, Tube
- FormCream
- Brand NameOpzelura
- ApplicationClinical
- Supply TypeExporter, Retailer, Distributor, Importer
- Preferred Buyer Location All over the world
Opzelura (ruxolitinib) is a topical Janus kinase (JAK) inhibitor. It's a non-steroid cream used to treat atopic dermatitis (eczema) and nonsegmental vitiligo (a condition where skin loses its color) in adults and children ages 12 years and older.
View More Details